How it went for everyone who tried one of its treatments
Helped means they said it helped with what they took it for, which may be one symptom and not the illness. Each person counts once: someone who tried several of these treatments is split equally across those they said how it went for.
Shares are out of the 1,131 people who said how it went for at least one of them, each counted once, the parts rounded to whole people. 159 more tried one or credit the approach without saying how it went.
| How it went | People | Share |
|---|---|---|
| Helped a lot | 233 | 21% |
| Helped | 479 | 42% |
| No change | 126 | 11% |
| Worse | 237 | 21% |
| Much worse | 56 | 5% |
How it went for everyone who tried one of its treatments
Helped means they said it helped with what they took it for, which may be one symptom and not the illness. Each person counts once: someone who tried several of these treatments is split equally across those they said how it went for.
Shares are out of the 658 people who said how it went for at least one of them, each counted once, the parts rounded to whole people. 93 more tried one or credit the approach without saying how it went.
| How it went | People | Share |
|---|---|---|
| Helped a lot | 165 | 25% |
| Helped | 278 | 42% |
| No change | 72 | 11% |
| Worse | 117 | 18% |
| Much worse | 26 | 4% |
How it went for everyone who tried one of its treatments
Helped means they said it helped with what they took it for, which may be one symptom and not the illness. Each person counts once: someone who tried several of these treatments is split equally across those they said how it went for.
Shares are out of the 466 people who said how it went for at least one of them, each counted once, the parts rounded to whole people. 62 more tried one or credit the approach without saying how it went.
| How it went | People | Share |
|---|---|---|
| Helped a lot | 67 | 14% |
| Helped | 198 | 43% |
| No change | 55 | 12% |
| Worse | 116 | 25% |
| Much worse | 30 | 6% |
Among the 415 who credit it with their improvement, here’s how they are now
Credit it means they say it’s one reason they got better.
Where each person was at the end of their story, or in their latest post that says how they are, compared with their worst point.
| Outcome described | People | Share |
|---|---|---|
| Recovered | 12 | 3% |
| Near normal | 49 | 12% |
| Much better | 156 | 38% |
| Somewhat better | 159 | 38% |
| Relapsed | 38 | 9% |
| Outcome unclear | 1 | — |
Did it last?
- 26 of 415 said the benefit of a treatment in this approach wore off (12 of them among the 38 who relapsed).
- 234 of 415 say they still need to keep doing something (not always one in this approach) to stay well.
Among the 275 who credit it with their improvement, here’s how they are now
Credit it means they say it’s one reason they got better.
Where each person was at the end of their story, or in their latest post that says how they are, compared with their worst point.
| Outcome described | People | Share |
|---|---|---|
| Recovered | 9 | 3% |
| Near normal | 45 | 17% |
| Much better | 102 | 37% |
| Somewhat better | 90 | 33% |
| Relapsed | 28 | 10% |
| Outcome unclear | 1 | — |
Did it last?
- 21 of 275 said the benefit of a treatment in this approach wore off (11 of them among the 28 who relapsed).
- 161 of 275 say they still need to keep doing something (not always one in this approach) to stay well.
Among the 139 who credit it with their improvement, here’s how they are now
Credit it means they say it’s one reason they got better.
Where each person was at the end of their story, or in their latest post that says how they are, compared with their worst point.
| Outcome described | People | Share |
|---|---|---|
| Recovered | 3 | 2% |
| Near normal | 4 | 3% |
| Much better | 54 | 39% |
| Somewhat better | 68 | 49% |
| Relapsed | 10 | 7% |
Did it last?
- 5 of 139 said the benefit of a treatment in this approach wore off (1 of them among the 10 who relapsed).
- 73 of 139 say they still need to keep doing something (not always one in this approach) to stay well.
Everyone · not split by condition
By how ill people were
Only the 415 who credit this approach, so people it didn’t help or made worse aren’t here. How they are now is their outcome overall.
| Severity at worst | How they are now | n | Recovered or near normal |
|---|---|---|---|
| Mild | 55 | 29% | |
| Moderate | 114 | 8% | |
| Severe | 142 | 18% | |
| Very severe | 26 | 8% | |
| Not stated | 78 | 10% |
| At worst | Outcome | People | Share |
|---|---|---|---|
| Mild | Recovered | 2 of 55 | 4% |
| Mild | Near normal | 14 of 55 | 25% |
| Mild | Much better | 14 of 55 | 25% |
| Mild | Somewhat better | 24 of 55 | 44% |
| Mild | Relapsed | 1 of 55 | 2% |
| Moderate | Recovered | 3 of 114 | 3% |
| Moderate | Near normal | 6 of 114 | 5% |
| Moderate | Much better | 43 of 114 | 38% |
| Moderate | Somewhat better | 50 of 114 | 44% |
| Moderate | Relapsed | 12 of 114 | 10% |
| Severe | Recovered | 4 of 142 | 3% |
| Severe | Near normal | 22 of 142 | 15% |
| Severe | Much better | 63 of 142 | 45% |
| Severe | Somewhat better | 37 of 142 | 26% |
| Severe | Relapsed | 16 of 142 | 11% |
| Very severe | Recovered | 1 of 26 | 4% |
| Very severe | Near normal | 1 of 26 | 4% |
| Very severe | Much better | 15 of 26 | 58% |
| Very severe | Somewhat better | 5 of 26 | 19% |
| Very severe | Relapsed | 4 of 26 | 15% |
| Not stated | Recovered | 2 of 77 | 3% |
| Not stated | Near normal | 6 of 77 | 7% |
| Not stated | Much better | 21 of 77 | 27% |
| Not stated | Somewhat better | 43 of 77 | 56% |
| Not stated | Relapsed | 5 of 77 | 7% |
Everyone · not split by condition
Treatments in this approach
The bar (How it went) and the line under each name are among everyone on the site who tried it and said how it went, the same numbers as on each treatment’s own page. Recovered and Faded are among the people here who credit it. Grey numbers rest on fewer than 10 people; a faded share in red is a third or more.
Fewer than 3 people here credit these, so they aren’t ranked: Dulaglutide (Trulicity).
20 of the 415 people
See all 415 stories-
Housebound and mostly in bed with ME/CFS, now much better on rapamycin and low-carb diet
Ill for over a decade, Flint 23355 was at worst housebound and mostly in bed. Over the years she improved, crediting a low-carb, high-fat diet, iron infusions and rapamycin at 4 mg, which helped PEM after a direct 6 mg start caused a massive crash; weekly…
-
Severe, housebound ME/CFS, somewhat better with pacing and low-dose naltrexone
A UK woman ill with ME/CFS for eight years, severe and housebound since 2021 after graded walks left her wheelchair dependent. She credited pacing and low-dose naltrexone with steady gains, and later a low-histamine diet with curing insomnia, migraines,…
-
Long COVID at its worst mostly lying down, now nearly back to normal with Zepbound
Ill with long COVID from July 2024; at worst sleeping or lying down most of the day, barely functioning, with fatigue, PEM, brain fog, palpitations and POTS. Antihistamines and supplements raised energy within a week, and nattokinase, bromelain and curcumin…
-
Housebound with ME/CFS and brain fog, now much better with pacing and antihistamines
Ill from March 2020, they were housebound with POTS, brain fog and PEM early on, and in May 2023 said treatments had taken them from about 30% to 70% of normal. Blood thinners, guanfacine, antihistamines, continuous progesterone, pacing and other medications…
-
Severe ME/CFS, housebound and often bedbound; walking better after physio, then relapsed
Pebble 29054, in the UK, has suspected ME/CFS and describes a decline from mild to severe after NHS GET/CBT and exercise, now housebound and often bedbound with crashes, sleep disruption, headaches, dizziness, GI/IBS and electrolyte problems. A private…
-
Long COVID crashes and wrecked gut, now near normal on antihistamines and diet
Badger 97535 developed long COVID after a covid infection in early 2021. He worked through months of 2-4 hours' sleep early on, a wrecked gut, mast cell reactions and flu-like crashes after exercise. Antihistamines, keto and very-low-calorie diets, PEA,…
-
Housebound with ME/CFS, improved on LDN and memantine then relapsed
After COVID in August 2024 they were housebound for months with severe GI flares, then fatigue, body and joint pain and brain fog. They credited low-dose naltrexone and memantine for lifting them from housebound to roughly 75–80% recovered, with semaglutide…
-
Long COVID made work impossible, now somewhat better with pacing and GLP-1 drugs
He caught COVID in 2022 during Omicron when his son started daycare and kept getting sicker as daycare infections piled up; symptoms peaked about a year in and work became impossible. He improved after a long COVID clinic helped with management and he…
-
Debilitated by long COVID with PEM and brain fog, now much better; clonidine helped
A man in his fifties with ME/CFS after COVID in July 2022 had four rough months before a booster brought full recovery, then cycles of relapse and partial recovery. A September 2023 sickness left him debilitated and forced early retirement. PEM, fatigue and…
-
Housebound and mostly bedbound with ME/CFS, now much better with pacing and support
They fell ill in 2018 at 18 and spent three years housebound and mostly bedbound, unable to bathe or feed themselves, worsening further after graded exercise therapy. After diagnosis, they followed a strict pacing plan with a therapist and family support,…
-
Housebound with long COVID, now much better after NADH and citrulline malate
Long COVID with ME/CFS, POTS, MCAS and EDS, following vaccine-triggered symptoms that worsened with infection; she lost her job in February 2025 and autumn crashes left her housebound. By June 2025, NADH, citrulline malate, vagus nerve stimulation and LDN…
-
Nearly bedbound with long COVID, now close to normal after ganglion blocks and nicotine
A former daily 5K runner, he caught COVID and was nearly bedbound in the second month with dysautonomia and PEM. Over more than two years he tried many treatments, crediting stellate ganglion blocks and nicotine, and was trying rapamycin. He was not fully…
-
Bedbound with ME/CFS after COVID, some improvement with low-dose naltrexone and ivabradine
She had 15 years of gradual ME/CFS symptoms with teenage EBV and crashes during her PhD, then became bedbound after COVID in early 2024. Diagnosed with ME/CFS, POTS, MCAS and hEDS in 2025, she credits low-dose naltrexone, ivabradine, H1/H2 antihistamines and…
-
Bedbound with ME/CFS, low-dose naltrexone and GLP-1 eased symptoms but she worsened again
She fell ill with mild ME/CFS after swine flu in 2009 and stayed largely functional, including a two-year remission, until COVID-19 in 2020 made her moderate and then severe. Pushing through, physical therapy and repeated infections lowered her baseline…
-
Bedbound with ME/CFS for three years, now much better with methylene blue
Undiagnosed mild ME/CFS for years, Hill 46448 became severe after a concussion and a crash that left her bedbound about three years, needing a power wheelchair and diapers. She credits compounded methylene blue most, alongside POTS drugs, LDN, NAD-ketamine…
-
Nearly bedbound with long COVID, now somewhat better with red light therapy and rest
Fell ill with COVID-19 in March 2020 and worsened over five years to nearly totally bedbound. Pfizer jabs brought remissions of weeks, but overdoing activity during them set them back. Red light therapy from December 2024 and aggressive rest lifted them out…
-
Long COVID with PEM and brain fog, much better after Safe and Sound Protocol and IVIG
A physician in his fifties developed ME/CFS-style long COVID after a mild second COVID infection in August 2023, with dysautonomia, orthostatic intolerance, PEM and brain fog. He kept working only by heavy pacing. The Safe and Sound Protocol helped him get…
-
Off work with long COVID for three months, now 60-80% of normal after tirzepatide
Pelican 87385 became ill with long COVID and at his worst was off work on disability for three months. A low-histamine diet, blood-sugar control, LDN for deep sleep, guanfacine for brain fog and NAD+ injections slowly helped; tirzepatide was the biggest help…
-
Almost bed-bound with long COVID, much better after radical rest and celecoxib
A retired tech lawyer in her sixties developed long COVID after her third infection, with PEM, fever and exhaustion leaving her almost bed-bound. About four months of radical rest, celecoxib, low-dose Celexa and a probiotic helped; Celexa plus cautious 5-HTP…
-
ME/CFS with PEM and brain fog, much better with vitamin D and LDN
Summit 65177 has ME/CFS with PEM, brain fog and muscle and joint pain; insomnia came with treatments. Doubling vitamin D raised energy and reduced PEM and muscle pain; low-dose naltrexone raised energy and reduced PEM, brain fog and pain, but caused insomnia…
The newest 20 people who credit GLP-1 drugs.
20 of the 275 people
See all 275 stories-
Long COVID at its worst mostly lying down, now nearly back to normal with Zepbound
Ill with long COVID from July 2024; at worst sleeping or lying down most of the day, barely functioning, with fatigue, PEM, brain fog, palpitations and POTS. Antihistamines and supplements raised energy within a week, and nattokinase, bromelain and curcumin…
-
Long COVID crashes and wrecked gut, now near normal on antihistamines and diet
Badger 97535 developed long COVID after a covid infection in early 2021. He worked through months of 2-4 hours' sleep early on, a wrecked gut, mast cell reactions and flu-like crashes after exercise. Antihistamines, keto and very-low-calorie diets, PEA,…
-
Long COVID made work impossible, now somewhat better with pacing and GLP-1 drugs
He caught COVID in 2022 during Omicron when his son started daycare and kept getting sicker as daycare infections piled up; symptoms peaked about a year in and work became impossible. He improved after a long COVID clinic helped with management and he…
-
Debilitated by long COVID with PEM and brain fog, now much better; clonidine helped
A man in his fifties with ME/CFS after COVID in July 2022 had four rough months before a booster brought full recovery, then cycles of relapse and partial recovery. A September 2023 sickness left him debilitated and forced early retirement. PEM, fatigue and…
-
Housebound with long COVID, now much better after NADH and citrulline malate
Long COVID with ME/CFS, POTS, MCAS and EDS, following vaccine-triggered symptoms that worsened with infection; she lost her job in February 2025 and autumn crashes left her housebound. By June 2025, NADH, citrulline malate, vagus nerve stimulation and LDN…
-
Nearly bedbound with long COVID, now close to normal after ganglion blocks and nicotine
A former daily 5K runner, he caught COVID and was nearly bedbound in the second month with dysautonomia and PEM. Over more than two years he tried many treatments, crediting stellate ganglion blocks and nicotine, and was trying rapamycin. He was not fully…
-
Nearly bedbound with long COVID, now somewhat better with red light therapy and rest
Fell ill with COVID-19 in March 2020 and worsened over five years to nearly totally bedbound. Pfizer jabs brought remissions of weeks, but overdoing activity during them set them back. Red light therapy from December 2024 and aggressive rest lifted them out…
-
Long COVID with PEM and brain fog, much better after Safe and Sound Protocol and IVIG
A physician in his fifties developed ME/CFS-style long COVID after a mild second COVID infection in August 2023, with dysautonomia, orthostatic intolerance, PEM and brain fog. He kept working only by heavy pacing. The Safe and Sound Protocol helped him get…
-
Off work with long COVID for three months, now 60-80% of normal after tirzepatide
Pelican 87385 became ill with long COVID and at his worst was off work on disability for three months. A low-histamine diet, blood-sugar control, LDN for deep sleep, guanfacine for brain fog and NAD+ injections slowly helped; tirzepatide was the biggest help…
-
Almost bed-bound with long COVID, much better after radical rest and celecoxib
A retired tech lawyer in her sixties developed long COVID after her third infection, with PEM, fever and exhaustion leaving her almost bed-bound. About four months of radical rest, celecoxib, low-dose Celexa and a probiotic helped; Celexa plus cautious 5-HTP…
-
Bedbound with long COVID, now much better after pacing and ozone therapy
They fell ill with long COVID in September 2022 after a second infection, bedbound and very severe at first. Improvement was very slow: they credited ozone therapy, weekly 72-hour fasts, NAD+ IVs (€207 each) and later home injections, the KPV peptide and…
-
Long COVID with passing out, vomiting and migraines, now much better with ketotifen, LDN
Tulip 99250 had Lyme disease and MCAS before COVID in 2020 made everything worse; at the worst they were passing out, vomiting, with frightening migraines and too exhausted to think or walk. Ketotifen, LDN 4 mg and POTS measures helped, then Zepbound from…
-
Long COVID at 25% function at worst, now much better after treating migraine and POTS
A bad virus in 2018 led to ME/CFS; Covid in 2020 took them from mild to moderate-severe, and after a booster in early 2022 migraines became daily and at worst they were largely in a dark room at about 25% function. Treating migraine, POTS and MCAS helped; by…
-
Housebound with long COVID for months, now much better with metoprolol and cardiac rehab
After COVID in summer 2022 they never recovered and were housebound for months, often too sick to lie down, slowly improving with metoprolol, a stimulant, muscle relaxants, sleep medication and cardiac rehab. By 2024 they were working full time but remained…
-
Unable to walk for a few weeks with long COVID, now much better after meditation and LDN
Fjord 60658 caught COVID in March 2020 and long COVID began that June, leaving them unable to walk for a few weeks. Improvement came about two years in, after months of disability leave spent meditating in a dark room, and later nortriptyline, LDN and sleep…
-
Long COVID, bedbound after graded walking, now somewhat better with pacing and rest
Fell ill after a presumed COVID infection in December 2022 and was diagnosed with ME/CFS in June 2024, after fatigue, PEM, chest pain and brain fog. Following their doctor's graded walking advice left them bedbound for close to a year. They credited radical…
-
Long COVID's first year horrible, now somewhat better; Bezisterim trial helped then faded
Trail 70876 has had long COVID since January 2021; the first year was horrible. They are now semi-recovered and can work full time remotely only with accommodations, walk the dog a little and do basic chores, but limit social contact and nap some days. A…
-
Long COVID sinus tachycardia and brain pressure, somewhat better on ivabradine and PT
After COVID in August 2023 (18 days ill, two hospital visits) they developed inappropriate sinus tachycardia and raised intracranial pressure and barely remember 2024. Ivabradine from December 2023 and autonomic physical therapy cut their tachycardic burden…
-
Long COVID with daily migraines, PEM and POTS, now almost back to normal after pacing
Glade 22757 has had long COVID since 2020, with daily migraines, PEM, MCAS, POTS and light, sound and smell sensitivity. Pushing through the first two to three years made them worse, so they quit work and slowed down. Pacing, scheduled rest, vestibular…
-
Long COVID fatigue and brain fog, somewhat better after LDN and metformin
After a COVID infection in 2022, Puffin 93772 was left with fatigue, brain fog, PEM and exercise intolerance that kept her working from home and resting most days. Paxlovid lifted symptoms for two weeks; she then slipped back down, though her baseline ended…
The newest 20 people with long COVID who credit GLP-1 drugs.
20 of the 139 people
See all 139 stories-
Housebound and mostly in bed with ME/CFS, now much better on rapamycin and low-carb diet
Ill for over a decade, Flint 23355 was at worst housebound and mostly in bed. Over the years she improved, crediting a low-carb, high-fat diet, iron infusions and rapamycin at 4 mg, which helped PEM after a direct 6 mg start caused a massive crash; weekly…
-
Severe, housebound ME/CFS, somewhat better with pacing and low-dose naltrexone
A UK woman ill with ME/CFS for eight years, severe and housebound since 2021 after graded walks left her wheelchair dependent. She credited pacing and low-dose naltrexone with steady gains, and later a low-histamine diet with curing insomnia, migraines,…
-
Housebound with ME/CFS and brain fog, now much better with pacing and antihistamines
Ill from March 2020, they were housebound with POTS, brain fog and PEM early on, and in May 2023 said treatments had taken them from about 30% to 70% of normal. Blood thinners, guanfacine, antihistamines, continuous progesterone, pacing and other medications…
-
Severe ME/CFS, housebound and often bedbound; walking better after physio, then relapsed
Pebble 29054, in the UK, has suspected ME/CFS and describes a decline from mild to severe after NHS GET/CBT and exercise, now housebound and often bedbound with crashes, sleep disruption, headaches, dizziness, GI/IBS and electrolyte problems. A private…
-
Housebound with ME/CFS, improved on LDN and memantine then relapsed
After COVID in August 2024 they were housebound for months with severe GI flares, then fatigue, body and joint pain and brain fog. They credited low-dose naltrexone and memantine for lifting them from housebound to roughly 75–80% recovered, with semaglutide…
-
Housebound and mostly bedbound with ME/CFS, now much better with pacing and support
They fell ill in 2018 at 18 and spent three years housebound and mostly bedbound, unable to bathe or feed themselves, worsening further after graded exercise therapy. After diagnosis, they followed a strict pacing plan with a therapist and family support,…
-
Bedbound with ME/CFS after COVID, some improvement with low-dose naltrexone and ivabradine
She had 15 years of gradual ME/CFS symptoms with teenage EBV and crashes during her PhD, then became bedbound after COVID in early 2024. Diagnosed with ME/CFS, POTS, MCAS and hEDS in 2025, she credits low-dose naltrexone, ivabradine, H1/H2 antihistamines and…
-
Bedbound with ME/CFS, low-dose naltrexone and GLP-1 eased symptoms but she worsened again
She fell ill with mild ME/CFS after swine flu in 2009 and stayed largely functional, including a two-year remission, until COVID-19 in 2020 made her moderate and then severe. Pushing through, physical therapy and repeated infections lowered her baseline…
-
Bedbound with ME/CFS for three years, now much better with methylene blue
Undiagnosed mild ME/CFS for years, Hill 46448 became severe after a concussion and a crash that left her bedbound about three years, needing a power wheelchair and diapers. She credits compounded methylene blue most, alongside POTS drugs, LDN, NAD-ketamine…
-
ME/CFS with PEM and brain fog, much better with vitamin D and LDN
Summit 65177 has ME/CFS with PEM, brain fog and muscle and joint pain; insomnia came with treatments. Doubling vitamin D raised energy and reduced PEM and muscle pain; low-dose naltrexone raised energy and reduced PEM, brain fog and pain, but caused insomnia…
-
Mildly ill with ME/CFS, some days approaching moderate, much better with Yaz and GLP-1s
Gradual-onset ME/CFS from about 2020 left them mildly ill, approaching moderate some days, while they kept working. Continuous Yaz eased their PMDD and monthly crashes, and by early 2026 trying GLP-1s was helping quite a lot.
-
Moderate ME/CFS after mono, working full time from home, partly better with antivirals
A woman developed ME/CFS after mono in her late 30s, mild at first while chronic migraine developed; overwork and a 2021 inner-ear illness left her moderate, and a possible COVID infection worsened her. Botox, Ajovy and memantine controlled the migraines;…
-
Housebound with ME/CFS, needing help showering, now somewhat better with pacing and rest
Tern 17519 developed ME/CFS after brain and nerve damage from anoxia during a resuscitation, and also has POTS and peripheral neuropathy. An October 2024 virus crash left them housebound and needing help showering for about eight months; pacing and rest…
-
Lying down 17 hours a day with ME/CFS, now out most days on testosterone and antihistamines
Cove 95392 fell ill with COVID and developed ME/CFS, POTS and MCAS, spending years in the severe category and lying down 17 hours a day. The Patterson protocol in 2021 eased neuropathy, vertigo, fatigue and sleep but not the ME/CFS; two EATs and a stellate…
-
Severe ME/CFS after long COVID, barely off the couch, now much better with semaglutide
A Reddit user developed ME/CFS after long COVID and worsened from mild to severe, barely able to get off the couch, with showers triggering crashes. Alprazolam for a procedure restored energy, but microdosed semaglutide was the turning point: PEM fell to a…
-
Moderate ME/CFS with pain and brain fog, somewhat better with pacing and a GLP-1
Ill for several years with suspected ME/CFS, fibromyalgia, hypersomnia and celiac, this US patient described themselves as moderate rather than severe and never fully bedbound, with PEM, pain, brain fog and flu-like symptoms. Pacing evened out their week and…
-
ME/CFS after COVID, with crashes and PEM, now somewhat better with low-dose tirzepatide
Undiagnosed with ME/CFS, she dates her illness to a COVID infection about 18 months earlier. ADHD stimulants gave hours of wakefulness for 3-4 months but ended in a hard crash, burnout and PEM that lowered her baseline. Low-dose tirzepatide later brought…
-
ME/CFS close to housebound and 75% sedentary, now somewhat better with LDN and tirzepatide
Meadow 49369, a 40-year-old in the US, became ill around 2022 with leg pain followed by fatigue, and was diagnosed with ME/CFS, POTS and hEDS. A mild viral infection in January 2026 dropped her from mild to moderate, close to housebound and 75% sedentary.…
-
Unable to speak nearly two years with ME/CFS, now somewhat better on GLP-1
Cove 77840 was in a dark room, unable to speak, for nearly two years and needed their mother to care for them; they also had thoughts of ending their life. Over the last four months they improved very slowly, which they attributed to starting a GLP-1 drug,…
-
Bedbound with ME/CFS, now somewhat better and still crashing after exertion
Ill since at least 2018, when ME/CFS symptoms began; after his back gave out and physical therapy kept crashing him, Oak 91946 became bedbound and in bed 95-98% of the time, rarely leaving the house except for doctors. He describes himself as moderate to…
The newest 20 people with ME/CFS who credit GLP-1 drugs.